Analyst Ratings For NITE – Nightstar Therapeutics (NASDAQ:NITE)

Today, Wedbush reiterated its Outperform rating on NITE – Nightstar Therapeutics (NASDAQ:NITE) with a price target of $31.00.

Some recent analyst ratings include

• 4/5/2018-Wedbush Reiterated Rating of Outperform.
• 4/5/2018-Mizuho Reiterated Rating of Buy.
• 1/3/2018-Chardan Capital initiated coverage with a Buy rating.
• 10/23/2017-Leerink Swann initiated coverage with a Outperform rating.
• 10/23/2017-Jefferies Group initiated coverage with a Buy rating.
• 10/23/2017-BMO Capital Markets initiated coverage with a Outperform rating.

Recent Trading Activity for NITE – Nightstar Therapeutics (NASDAQ:NITE)
Shares of NITE – Nightstar Therapeutics closed the previous trading session at 12.33 +0.00 0.00% with 12.510000228881836 shares trading hands.